Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis

The USA Food and Drug Administration (FDA) issued warnings regarding the use of antipsychotics in patients with dementia in 2003 and 2005. We aimed to study the dose and duration of antipsychotic treatment in dementia, and to examine whether physicians' prescription behaviors changed after the...

Full description

Bibliographic Details

Published in:	Journal of the Formosan Medical Association
Main Authors:	Yi-Ting Lin, Tzung-Jeng Hwang, Jia-Chi Shan, Huey-Ling Chiang, Yi-Han Sheu, Hai-Gwo Hwu
Format:	Article
Language:	English
Published:	Elsevier 2015-02-01
Subjects:	agitation antipsychotic agents dementia quetiapine risperidone
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664612004378